Citation Capital's $1.2 Billion Debut Fund: Inside the Largest Female-Founded Buyout Raise Ever

TL;DR: Citation Capital, a Dallas and Greenwich-based buyout shop founded by two former Goldman Sachs and BDT Capital dealmakers, closed its first fund at $1.2 billion, hit its hard cap, and is now sitting on $2.1 billion in total investable capital with co-investment included. It's the largest female-founded buyout fund ever raised, but the label matters less than the mechanics: a first-time fund with no realized returns, four platform deals already on the books, and a bet that mid-cap industrials and consumer services still throw off cash even when credit is expensive.

Citation Capital announced on July 13, 2026 that it closed Fund I with $1.2 billion in total commitments, hitting a hard cap of $1.1 billion from third-party limited partners plus GP and affiliate capital, according to the firm's press release. Add co-investment capacity and Citation now controls roughly $2.1 billion in total assets under management, all before it's booked a single exit. I want to be clear about why that number is unusual: private equity fundraising has been stuck in a multi-year slump, LPs are over-allocated to illiquid assets after a weak exit environment, and first-time fund managers are the first casualty when institutional capital tightens up. Citation raised a hard-capped, oversubscribed $1.2 billion fund into that headwind. That's the story before you even get to the gender angle.

What Citation Actually Bought, and Why That Matters More Than the Headline

Citation Capital was founded in 2023 (some accounts list 2022, likely reflecting the gap between initial formation and formal LP fundraising) by Tiffany K. Hagge and Lydie B. Hudson, with Spencer Almy, Santiago Castelazo, and Dan Baginski rounding out the senior team, according to the Dallas Business Journal. The firm runs lean: about 22 employees managing $2.1 billion is a high dollar-per-headcount ratio even by buyout industry standards, where small deal teams routinely oversee capital far larger than their staff count would suggest at a bank or asset manager. That ratio is a deliberate structural choice in buyout investing generally, since these firms outsource day-to-day operations to the management teams of the companies they buy rather than running large in-house staffs the way a hedge fund or a corporate acquirer might. Hagge's background explains a lot of the LP interest. Per her Mergr investor profile, she originated or led transactions totaling roughly $25 billion in enterprise value across stints at BDT Capital Partners, Goldman Sachs Merchant Banking, and the CPP Investment Board (Canada's national pension manager, one of the largest institutional allocators in the world). She's a Dartmouth graduate and a former member of the U.S. Women's National ice hockey team, a detail I'd normally skip past except that it shows up in nearly every profile of her, suggesting the firm leans into it deliberately as part of the founder narrative it's selling to LPs. Hudson's and the rest of the team's specific prior firms aren't as fully documented in public filings, but the pattern among the named partners, Almy, Castelazo, and Baginski, points to a team assembled from established middle-market buyout shops rather than first-time dealmakers learning on the job with LP money.

Here's the part that gets buried under the "largest female-founded fund" framing: Citation isn't running a novel strategy. It's a conventional middle-market buyout shop targeting North American services, industrials, and consumer businesses, the same hunting ground as hundreds of other funds in the $1 billion to $3 billion range. The firm has already deployed capital into four platform companies: Cibo Vita (a food manufacturer), Aptive Environmental (pest control services), Gallo Mechanical (mechanical contracting), and World Travel Holdings (travel services). That's a diversified spread across food, home services, industrial trades, and travel, which tells you Citation isn't making a single-sector bet. It also tells you the fund is already roughly a third to a half deployed by deal count for a vehicle that just finished raising, which is fast even by buyout standards.

The Math Behind the "Largest Female-Founded" Claim

Calling Citation the largest female-founded buyout fund in history is accurate, but it's worth putting the comparison set in context because the prior bar was not high. The table below lays out what "largest ever" actually competed against.

Fund	Close Size	Year	Notable Detail
Citation Capital Fund I	$1.2B ($1.1B hard cap + GP capital)	2026	$2.1B AUM with co-invest, 4 deals closed pre-close
Jo Natauri's Invidia Curie Fund I	Up to $850M targeted	2024 (filed)	Health and wellness focus
Vertu Capital	$300M	2023	First woman-founded PE firm in Canada
Aliph Capital	$200M	2025	First woman-founded PE firm in the Gulf region

Citation's $1.2 billion is roughly 1.4 times the size of the previous largest comparable raise and 4 to 6 times the size of the Vertu and Aliph funds. That's a real gap, not a rounding difference. But it also means the "female-founded buyout fund" category has been small enough that a single well-connected, well-pedigreed team with $25 billion of prior deal experience between them could reset the record on a first try. I'd read this less as "the market has arrived" and more as "the market had a gap this specific team was positioned to fill," given Hagge and Hudson's combined Rolodex from Goldman, BDT, and CPPIB. Each of the three comparison funds tells its own story. Vertu Capital, reported by The Globe and Mail as Canada's first woman-founded private equity firm, closed at $300 million in 2023 focused on enterprise software and technology-enabled services, a narrower sector bet than Citation's diversified industrials-and-services approach. Aliph Capital, covered by Semafor as the first woman-founded PE firm in the Gulf region, closed at $200 million in 2025, operating in a market with a fraction of the institutional LP base available to a Dallas or Greenwich-based fund targeting North American pensions and endowments. Jo Natauri's Invidia Curie Fund I, which Bloomberg reported was targeting up to $850 million in a 2024 regulatory filing and focuses on health and wellness, comes closest to Citation in ambition but still fell short of the eventual $1.2 billion Citation delivered. None of these funds is a failure by any reasonable measure. They're proof that female-founded buyout funds can raise real institutional capital at meaningfully different scales depending on sector focus, geography, and the specific LP networks the founding team can access.

Can an Accredited Investor Actually Get In?

This is the question I get most from AIN readers whenever a headline fund closes: is there a door in? For Citation specifically, the honest answer right now is no, not directly. Fund I closed with commitments already locked from institutional LPs, likely pensions, endowments, sovereign wealth allocators, and fund-of-funds, the typical buyer base for a $1.1 billion hard-capped vehicle. Minimum commitment sizes for funds at this scale routinely run $5 million to $25 million or more, which puts direct LP access out of reach for all but the largest family offices among accredited investors. That's simply a function of how buyout funds are structured under Regulation D: they're raised as private placements limited to accredited or qualified purchasers, with subscription documents and minimums set high enough to keep the LP roster small and administratively manageable for a 22-person team. That doesn't mean the door is permanently shut. There are three realistic paths for an accredited investor who wants exposure to this kind of strategy, if not this specific fund:

• Secondary market interests. Once Fund I is a few years into its investment period, LP stakes sometimes trade on the secondaries market through platforms and intermediaries that deal in fractional interests, though minimums are still often six figures and access typically runs through a placement agent or wealth manager.
• Feeder funds and interval funds. Wealth platforms increasingly wrap institutional PE fund access into feeder vehicles or semi-liquid interval funds with lower minimums, sometimes $25,000 to $50,000. Whether Citation ever opens a feeder is unannounced, but the mechanism exists in the market broadly.
• Public proxies. Business development companies (BDCs) and publicly traded alternative asset managers give you correlated, liquid exposure to the same middle-market buyout theme without the lockup, at the cost of diluted upside and added public-market volatility.

None of these get you into Citation Capital Fund I specifically. What they get you is exposure to the same thesis Citation is underwriting: that mid-cap services and industrials businesses, bought at reasonable multiples with operational improvement plans, can still generate buyout-grade returns in a higher-rate environment. That's the trade you're actually evaluating, not the brand name on the fund.

Where I'd Push Back

I think the coverage of this raise has undersold the risk side, so let me lay it out plainly. First, this is a first-time fund with zero realized track record. Every prior deal Hagge, Hudson, and the team sourced happened under someone else's fund and someone else's carry structure. Past deal experience at BDT or Goldman Merchant Banking is a real signal of skill, but it isn't the same as proof that this specific team, with this specific fee structure and this specific set of LPs looking over their shoulder, can execute a full buy-improve-sell cycle and return capital at the multiple LPs are underwriting to. Fee and carry terms haven't been disclosed publicly, which is normal for a fund this size but means outside observers, including AIN readers evaluating adjacent exposure, are taking the LP base's word for it that terms were reasonable. Second, four platform deals against $2.1 billion in AUM is a concentrated book for a fund this early. If even one or two of Cibo Vita, Aptive Environmental, Gallo Mechanical, or World Travel Holdings underperforms, whether from a demand shock in travel, labor cost inflation in pest control and mechanical trades, or a food safety or input-cost issue at Cibo Vita, the fund's overall return profile takes a disproportionate hit relative to a more deal-diversified vehicle with 12 to 15 platforms. Buyout funds typically want a wider spread precisely to dilute single-company risk. Citation's early pace suggests either high conviction or fast capital deployment pressure, and those two things aren't always the same thing. Deployment speed can reflect a genuinely strong deal pipeline built over years at prior firms, or it can reflect pressure to put LP capital to work quickly once a fund closes. Both explanations are plausible here, and outside observers won't know which one dominates until the fund reports its first few years of operating results. Third, buyout math depends on exit multiples and debt costs that are less friendly now than during the 2010s buyout boom this generation of dealmakers largely trained in. Hagge's $25 billion in prior deal experience was mostly built in a lower-rate environment. That doesn't invalidate the thesis, but it does mean the playbook needs adjusting, and adjusting a playbook is exactly the kind of thing you can't fully verify until a fund has sold a few companies and the numbers are in a filing somewhere, not a press release.

What To Actually Do With This

If you're an accredited investor intrigued by the Citation story, the actionable step isn't chasing this fund, it's closed. The actionable step is using this as a prompt to ask your wealth manager or RIA three specific questions: whether any feeder or interval fund on your platform has exposure to middle-market North American buyout strategies in the services and industrials space, what the realized (not projected) net IRR has been on comparable vintage-year funds your advisor has access to, and what the actual minimum check size and lockup terms are before you commit anything. Track Citation's follow-on activity, too. If it announces a Fund II within three to four years at a materially larger size, that's a stronger signal of institutional confidence than the Fund I close itself, because it means LPs came back after watching the first cohort of deals develop rather than betting on pedigree alone.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.